Combination of sofosbuvir and velpatasvir (Epclusa®)
Drug profileGastroent Hepatol 2016; 70(6): 553–554. doi:10.14735/amgh2016553
pdf Petr UrbánekUrsodeoxycholic acid
Drug profileGastroent Hepatol 2016; 70(5): 457–462. doi:10.14735/amgh2016457
Literaturepdf Jan JuřicaOlysio® (simeprevir)
Drug profileGastroent Hepatol 2016; 70(4): 368–370. doi:10.14735/amgh2016368
pdf Irena HejlováThe Mutaflor® – Escherichia coli (Nissle 1917), serotype O6: K5: H1 – the best researched probiotic available
Drug profileGastroent Hepatol 2016; 70(3): 281–282. doi:10.14735/amgh2016281
Literaturepdf Milan LukášEziclen® – reliable method for cleaning the bowel before the colonoscopic examination
Drug profileGastroent Hepatol 2016; 70(2): 188–189. doi:10.14735/amgh2016188
Literaturepdf Milan LukášCortiment® – first oral budesonide for the treatment of mild to middle active ulcerative colitis
Drug profileGastroent Hepatol 2016; 70(1): 95–96. doi:10.14735/amgh201695
Literaturepdf Milan LukášUrsodeoxycholic acid (Ursosan® capsules)
Drug profileGastroent Hepatol 2015; 69(6): 588. doi:10.14735/amgh2015588
Literaturepdf Milan LukášBudenofalk Uno 9 mg gastro-resistant granules
Drug profileGastroent Hepatol 2015; 69(4): 392–393.
Literaturepdf Milan LukášSaccharomyces boulardii – probiotic yeast from Indochina
Drug profileGastroent Hepatol 2015; 69(3): 269–270. doi:10.14735/amgh2015269
Literaturepdf Milan LukášMaltofer®
Drug profileGastroent Hepatol 2015; 69(2): 180-182. doi:10.14735/amgh2015180
Literaturepdf Milan Lukáš